394 related articles for article (PubMed ID: 8786385)
1. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
Mrak RE; Sheng JG; Griffin WS
J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.
Sheng JG; Mrak RE; Bales KR; Cordell B; Paul SM; Jones RA; Woodward S; Zhou XQ; McGinness JM; Griffin WS
J Neurochem; 2000 Jan; 74(1):295-301. PubMed ID: 10617132
[TBL] [Abstract][Full Text] [Related]
3. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease].
Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.
Griffin WS; Sheng JG; Roberts GW; Mrak RE
J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis.
Sheng JG; Ito K; Skinner RD; Mrak RE; Rovnaghi CR; Van Eldik LJ; Griffin WS
Neurobiol Aging; 1996; 17(5):761-6. PubMed ID: 8892349
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1996 Aug; 22(4):334-41. PubMed ID: 8875468
[TBL] [Abstract][Full Text] [Related]
7. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
8. S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures.
Li Y; Wang J; Sheng JG; Liu L; Barger SW; Jones RA; Van Eldik LJ; Mrak RE; Griffin WS
J Neurochem; 1998 Oct; 71(4):1421-8. PubMed ID: 9751173
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition.
Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528
[TBL] [Abstract][Full Text] [Related]
11. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.
Sheng JG; Mrak RE; Griffin WS
J Neurosci Res; 1994 Nov; 39(4):398-404. PubMed ID: 7884819
[TBL] [Abstract][Full Text] [Related]
12. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
13. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
14. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
[TBL] [Abstract][Full Text] [Related]
15. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
16. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.
Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ
FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568
[TBL] [Abstract][Full Text] [Related]
17. Regression stage senile plaques in the natural course of Alzheimer's disease.
Oide T; Kinoshita T; Arima K
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
[TBL] [Abstract][Full Text] [Related]
18. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms.
Sheng JG; Mrak RE; Griffin WS
Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease.
Masliah E; Mallory M; Deerinck T; DeTeresa R; Lamont S; Miller A; Terry RD; Carragher B; Ellisman M
J Neuropathol Exp Neurol; 1993 Nov; 52(6):619-32. PubMed ID: 8229081
[TBL] [Abstract][Full Text] [Related]
20. Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.
Kelley CM; Perez SE; Overk CR; Wynick D; Mufson EJ
J Alzheimers Dis; 2011; 25(3):491-504. PubMed ID: 21471639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]